ANEW 202
Alternative Names: ANEW-202Latest Information Update: 21 Aug 2024
At a glance
- Originator ANEW MEDICAL
- Class Gene therapies
- Mechanism of Action Gene transference; Klotho protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alzheimer's disease; Amyotrophic lateral sclerosis; Parkinson's disease
Most Recent Events
- 15 Aug 2024 ANEW MEDICAL has patent protection for Klotho gene sequence and gene delivery systems in US
- 08 Aug 2024 ANEW MEDICAL has patent protection for Klotho gene sequence and gene delivery systems in China
- 08 Aug 2024 ANEW MEDICAL plans a clinical trial in Neurodegenerative disorders in late 2025